Healthcare Communication Platform, Pulsara, Announces Release of FREE COVID-19 Management Package

Pulsara's COVID-19 package enables networked communication (including HIPAA-compliant live video and messaging) across organizations at no charge.
16-Mar-2020 9:00 AM EDT, by Pulsara

 

 

Newswise — BOZEMAN, Mont., March 15, 2020 /PRNewswire/ -- Pulsara announced today that they have released a COVID-19 management package available to all EMS and healthcare organizations in the United States for free.

"With confirmed Coronavirus Disease 2019 cases on the rise in the U.S., we know that many EMS and healthcare organizations are rapidly preparing for the management of this crisis within their communities," said Pulsara Founder and CEO, Dr. James Woodson. "Inter-organization communication has never been more important than it is right now. In this time of need, we are fortunate to be able to serve."

There are several ways clinicians can use the mHealth Pulsara communication platform to help their teams manage patients with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). During the pandemic, Pulsara for COVID-19 is free for teams using the platform for ANY combination of these goals.

Goal #1: Mitigate Patient Surge
EMS, hospitals, urgent cares, nursing homes, freestanding EDs ...

  • Leverage video telemedicine and messaging for medical control scenarios, transporting only the patients who absolutely need to visit the hospital.

Goal #2: Limit Transfers to Clinically Appropriate Cases
Interfacility Communications — Department of Health included

  • Instead of a phone call or radio report, utilize multimedia capabilities including secure video calls, images, messaging, and audio clips to evaluate the patient and determine the appropriate disposition.

Goal #3: Limit Exposure to Clinicians and Other Patients
EMS/Ambulance to Emergency Department

  • Through early notification, Pulsara allows EMT and Paramedic teams to adequately prepare for COVID-19 patient arrival, limiting exposure to clinicians and other patients at receiving emergency departments.

Goal #4: Limit Repeat Clinician Exposure AND Conserve Personal Protective Equipment (PPE)
Intrafacility Communication

  • Evaluation phase: In the ED, alternative screening sites, etc., care teams can use video telehealth and messaging to minimize the number of clinicians and resources in direct contact with COVID-19 patients.
  • Inpatient phase: Reduce clinician exposure by reducing trips into the room. Use live video and messaging during patient assessments and medical rounds.

Goal #5: Secure Outpatient Medical Isolation (Quarantine) Communication
Patient to Provider

  • Facilitate regular check-ins with health departments or providers via live video calls, audio clips, messaging, vital signs, and more. This provides consolidated data for the duration of the patient event.

"During a time where social distancing is necessary, clinicians need a way to simply and securely connect with each other," said Kris Kaull, Chief Marketing Officer and Flight Paramedic. "Helping the medical community manage patient surge, preserve Personal Protective Equipment and limit exposure to protect our clinicians and their patients is at the forefront of our minds."

Pulsara has a dedicated team standing by to promptly and remotely provide consultations, demonstrations, implementations, training, and customer support for Pulsara's COVID-19 workflows. Those interested in using Pulsara for COVID-19 can sign up right here.

ABOUT PULSARA
Pulsara is a mobile-first healthcare communication platform that connects teams across organizations. What makes Pulsara unique is its ability to enable dynamic networked communications for any illness or injury. With Pulsara, clinicians can add a new organization, team, or specialist to any patient event, dynamically building a care team even as the patient condition and location are constantly evolving.

Simply CREATE a dedicated patient channel. BUILD the team. And, COMMUNICATE using audio, live video, instant messaging, data, images, and key benchmarks. Studies report an average decreased treatment time of nearly 30% when using Pulsara. Pulsara is the evidence-based standard of care. For more information, visit https://www.pulsara.com


 



Filters close

Showing results

110 of 6084
Newswise: Public
Released: 28-Jul-2021 2:45 PM EDT
Highly Potent, Stable Nanobodies Stop SARS-CoV-2
Max Planck Society (Max-Planck-Gesellschaft)

Göttingen researchers have developed mini-antibodies that efficiently block the coronavirus SARS-CoV-2 and its dangerous new variants.

Newswise: Public
Released: 28-Jul-2021 2:20 PM EDT
Psychological Consequences of COVID-19 in Health Care
University of Bonn

Physicians, nursing staff, medical technical assistants, and pastoral workers in hospitals: they have all been placed under severe strain by the Covid-19 pandemic.

Newswise: Public
Released: 28-Jul-2021 2:10 PM EDT
Why Lockdown in Africa Does Not Work as a First COVID-19 Pandemic Response
University of Johannesburg

In an African pandemic it is more productive to consider lockdowns, after using other non-medical measures first, Especially in countries with high levels of poverty and corruption, says Prof Nicholas Ngepah, a Professor of Economics at the University of Johannesburg in South Africa.

Newswise:Video Embedded how-to-talk-with-people-who-are-not-vaccinated-against-covid-19
VIDEO
Released: 28-Jul-2021 1:40 PM EDT
How to Talk With People Who Are Not Vaccinated Against COVID-19
Cedars-Sinai

Even though she has asthma, putting her at higher risk for severe complications from COVID-19, Angela Reeves-Flores, 33, waited until a week ago to get vaccinated.

Newswise: Indian Women’s Nutrition Suffered During COVID-19 Lockdown
Released: 28-Jul-2021 12:50 PM EDT
Indian Women’s Nutrition Suffered During COVID-19 Lockdown
Cornell University

A new study from Cornell University finds the nationwide lockdown India imposed last year in response to COVID-19 caused disruptions that negatively impacted women’s nutrition.

Released: 28-Jul-2021 12:00 PM EDT
MD Anderson Research Highlights for July 28, 2021
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include a newly discovered protein that controls B cell survival, understanding epigenetic changes in malignant peripheral nerve sheath tumors (MPNSTs) and melanoma, identifying a protein that protect genome stability, developing novel cell therapies for COVID-19, a new option for treating neuropathic pain, exosome delivery of CRISPR/Cas9 to pancreatic cancer, discovering how cancer cells tolerate aneuploidy and the role of health disparities in long-term survival of adolescent and young adult patients with Hodgkin lymphoma.

Released: 28-Jul-2021 11:30 AM EDT
Study Reveals Characteristics of SARS-CoV-2 Spike Protein
University of Kentucky

A new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry provides foundational information about SARS-CoV-2’s spike protein.

access_time Embargo lifts in 2 days
Embargo will expire: 4-Aug-2021 9:00 AM EDT Released to reporters: 28-Jul-2021 11:15 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Aug-2021 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: UIC Awarded $6 Million to Develop Potential COVID-19 Treatment
Released: 28-Jul-2021 10:15 AM EDT
UIC Awarded $6 Million to Develop Potential COVID-19 Treatment
University of Illinois Chicago

Researchers at the University of Illinois Chicago are developing a potential treatment for COVID-19, thanks to a $6 million technology and therapeutic development award from the U.S. Department of Defense supporting pre-clinical animal studies.

Newswise: Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Released: 28-Jul-2021 8:55 AM EDT
Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Chulalongkorn University

Cumulative stress, denial, and chronic depression are the byproducts of the COVID-19 pandemic. The Center for Psychological Wellness, Chulalongkorn University recommends ways to cope by harnessing positive energy from our heart.


Showing results

110 of 6084

close
1.14969